|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0004057,
umls-concept:C0008976,
umls-concept:C0019134,
umls-concept:C0030705,
umls-concept:C0034656,
umls-concept:C0035124,
umls-concept:C0035173,
umls-concept:C0038418,
umls-concept:C0155626,
umls-concept:C0210057,
umls-concept:C1028706,
umls-concept:C1707455,
umls-concept:C1947917
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
1997-10-31
|
|
pubmed:abstractText |
Thrombolytic therapy improves survival after myocardial infarction through reperfusion of the infarct-related artery. Thrombin generated during thrombolytic administration may reduce the efficacy of thrombolysis. A direct thrombin inhibitor may improve early patency rates.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0009-7322
|
|
pubmed:author |
pubmed-author:AdelmanBB,
pubmed-author:AdgeyA AAA,
pubmed-author:AylwardP EPE,
pubmed-author:BrownM AMA,
pubmed-author:CollinsRR,
pubmed-author:FrenchJ KJK,
pubmed-author:FreyM JMJ,
pubmed-author:HillisW SWS,
pubmed-author:MaraganoreJJ,
pubmed-author:NairRR,
pubmed-author:ShalevYY,
pubmed-author:WhiteH DHD
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
7
|
|
pubmed:volume |
96
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2155-61
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9337184-Analysis of Variance,
pubmed-meshheading:9337184-Antithrombins,
pubmed-meshheading:9337184-Aspirin,
pubmed-meshheading:9337184-Double-Blind Method,
pubmed-meshheading:9337184-Drug Administration Schedule,
pubmed-meshheading:9337184-Drug Therapy, Combination,
pubmed-meshheading:9337184-Female,
pubmed-meshheading:9337184-Heart Catheterization,
pubmed-meshheading:9337184-Heparin,
pubmed-meshheading:9337184-Hirudin Therapy,
pubmed-meshheading:9337184-Hirudins,
pubmed-meshheading:9337184-Humans,
pubmed-meshheading:9337184-Male,
pubmed-meshheading:9337184-Middle Aged,
pubmed-meshheading:9337184-Myocardial Infarction,
pubmed-meshheading:9337184-Peptide Fragments,
pubmed-meshheading:9337184-Recombinant Proteins,
pubmed-meshheading:9337184-Recurrence,
pubmed-meshheading:9337184-Streptokinase,
pubmed-meshheading:9337184-Thrombolytic Therapy
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) Trial Investigators.
|
|
pubmed:affiliation |
Green Lane Hospital, Auckland, New Zealand. white002@msn.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
